ストックスクリーナーアプリを入手
36.26
2.60%
0.92
Biohaven Ltd (BHVN) 最新ニュース
Geode Capital Management LLC Buys 44,174 Shares of Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Biohaven (NYSE:BHVN) Stock Price Down 6.1%What's Next? - MarketBeat
Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval - AOL
Bernstein reiterates Outperform rating on Biohaven stock, sees strong upside potential - Investing.com Australia
Biohaven's (BHVN) Overweight Rating Reaffirmed at Cantor Fitzgerald - MarketBeat
Biohaven (NYSE:BHVN) Given Buy Rating at HC Wainwright - MarketBeat
Is Biohaven Ltd. (BHVN) the Best Weight Loss Stock to Buy Now According to Hedge Funds? - Insider Monkey
Biohaven (NYSE:BHVN) Shares Gap DownWhat's Next? - MarketBeat
Biohaven Reports Positive Phase 1 Degrader Data, Achieving Deep Targeted IgG Reductions in the Lowest Subcutaneous Dose Tested; Announces NDA Submission for Troriluzole in SCA and Provides Other Key Program Updates - PR Newswire
Biohaven Ltd. (NYSE:BHVN) Holdings Boosted by Barclays PLC - MarketBeat
Wellington Management Group LLP Boosts Stock Holdings in Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Biohaven's SWOT analysis: neurological drug developer's stock poised for growth - Investing.com
12 Best Weight Loss Stocks to Buy According to Hedge Funds - Insider Monkey
State Street Corp Sells 393,278 Shares of Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Biohaven Announces Proposed Public Offering of Common Shares - The Eastern Progress Online
Learn to Evaluate (BHVN) using the Charts - Stock Traders Daily
Y Intercept Hong Kong Ltd Acquires Shares of 26,789 Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Biohaven Announces Pricing of $250 Million Public Offering of Common Shares - The Eastern Progress Online
Biohaven Ltd. (NYSE:BHVN) Shares Acquired by XTX Topco Ltd - MarketBeat
Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine - The Eastern Progress Online
Biohaven Presents New Data with BHV-7000 Once-Daily Extended-Rel - GuruFocus.com
Biohaven Pharma (BHVN) Presents New Data with BHV-7000 Once-Daily Extended-Release Formulation Demonstrating Excellent Safety Profile and Nonclinical Data Updates - StreetInsider.com
Biohaven Presents New Data with BHV-7000 Once-Daily Extended-Release Formulation Demonstrating Excellent Safety Profile and Nonclinical Data Updates at American Epilepsy Society 2024 Annual Meeting – Company AnnouncementFT.com - Financial Times
Fmr LLC Sells 13,092 Shares of Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Stifel Financial Corp Purchases 28,684 Shares of Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Biohaven Ltd. (NYSE:BHVN) Shares Sold by Redmile Group LLC - MarketBeat
Point72 Asset Management L.P. Has $74.97 Million Stock Position in Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Biohaven Ltd. (NYSE:BHVN) Stock Position Raised by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Biohaven shares target increased, rating held on FDA catalyst potential By Investing.com - Investing.com Australia
Charles Schwab Investment Management Inc. Has $31.62 Million Stock Position in Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Janus Henderson Group PLC Boosts Stock Position in Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Holocene Advisors LP Lowers Stock Position in Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Erste Asset Management GmbH Invests $2.62 Million in Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Analysts Set Biohaven Ltd. (NYSE:BHVN) Price Target at $62.75 - MarketBeat
Trading (BHVN) With Integrated Risk Controls - Stock Traders Daily
Fred Alger Management LLC Grows Position in Biohaven Ltd. (NYSE:BHVN) - MarketBeat
D.A. Davidson & CO. Makes New $1.20 Million Investment in Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Intech Investment Management LLC Acquires New Stake in Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Citigroup Inc. Has $5.99 Million Position in Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Biohaven Ltd. (NYSE:BHVN) Shares Sold by Eventide Asset Management LLC - MarketBeat
Biohaven's Revenue Path: SCA And Obesity Therapies (NYSE:BHVN) - Seeking Alpha
Algert Global LLC Acquires 24,990 Shares of Biohaven Ltd. (NYSE:BHVN) - MarketBeat
Biohaven’s Phase III SMA miss: was it the target or the trial design? - BioCentury
Biohaven's (BHVN) Buy Rating Reiterated at HC Wainwright - MarketBeat
Scholar Rock shares surge 26% as rival Biohaven misses SMA study goal - TradingPedia
Biohaven’s myostatin inhibitor fails in phase 3 spinal muscular atrophy trial - BioPharma-Reporter.com
Biohaven's spinal muscular atrophy drug fails to meet study goal - Reuters
Biohaven shares retains overweight rating on clinical trial By Investing.com - Investing.com South Africa
Biohaven shares retain Outperform rating as Baird highlights optimism for obesity Phase 2 trial By Investing.com - Investing.com South Africa
Scholar Rock Stock Jumps As Rival Biohaven's Muscle-Wasting Drug Flunks Pivotal Study - Benzinga
Biohaven muscle drug misses goal of SMA study, but advances in obesity - BioPharma Dive
Biohaven down 5% as spinal muscular atrophy asset misses primary endpoint - Seeking Alpha
Scholar Rock hits 3-year high on rival Biohaven's drug setback - XM
Biohaven Pharma (BHVN) Provides Update on Taldefgrobep Alfa Development Program - StreetInsider.com
Biohaven Provides Update on Taldefgrobep Alfa Development Program for Spinal Muscular Atrophy and Obesity - cnhinews.com
GSA Capital Partners LLP Sells 11,124 Shares of Biohaven Ltd. (NYSE:BHVN) - MarketBeat
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):